<DOC>
	<DOCNO>NCT02100683</DOCNO>
	<brief_summary>The Nit-Occlud PDA Post-Approval Study design continue evaluate safety effectiveness device post-approval phase .</brief_summary>
	<brief_title>Nit-Occlud PDA Post-Approval Study</brief_title>
	<detailed_description />
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<criteria>Angiographically confirm PDA minimum diameter &lt; 4 mm . Weight ≥ 5 kg . Age 6 month 21 year . Cardiac anomalies require surgery . Known bleed coagulation disorder . Febrile illness within 7 day plan procedure . Pregnancy . Pulmonary hypertension increase pulmonary vascular resistance ( ≥ 5 Wood Units ) . Hypersensitivity contrast medium . Known nickel allergy .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Occluder</keyword>
</DOC>